These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38950163)

  • 1. Evaluating patient-reported adherence and outcomes in specialty disease states: A dual-site initiative.
    Bryan ED; Renfro CP; Anguiano RH; Kumor L; DeClercq J; Choi L; Zuckerman AD
    J Manag Care Spec Pharm; 2024 Jul; 30(7):710-718. PubMed ID: 38950163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual and Community-Level Characteristics and Adherence to Specialty Medications.
    Kibbons AM; Moore R; Choi L; Peter M; Zuckerman AD
    J Pharm Pract; 2024 Apr; 37(2):279-286. PubMed ID: 36206399
    [No Abstract]   [Full Text] [Related]  

  • 3. Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.
    Zuckerman A; Crumb J; Kandah HM; Platt T; Duckworth D; Lo K; Mitchell D; Diamantides E; Streck CM; DeClercq J; Choi L; Patel R
    J Manag Care Spec Pharm; 2023 Jul; 29(7):740-748. PubMed ID: 37404071
    [No Abstract]   [Full Text] [Related]  

  • 4. Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population.
    Paolella D; Cherry E; Jolly JA; DeClercq J; Choi L; Zuckerman A
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1282-1288. PubMed ID: 31663457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Year Outcomes of an Integrated Multiple Sclerosis Disease Management Program.
    Groeneweg M; Forrester SH; Arnold B; Palazzo L; Zhu W; Yoon P; Scearce T
    J Manag Care Spec Pharm; 2018 May; 24(5):458-463. PubMed ID: 29694287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
    Kale HP; Patel AM; Carroll NV
    J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy.
    Petry L; Zuckerman AD; DeClercq J; Choi L; Lynch B; Saknini M
    J Manag Care Spec Pharm; 2023 Jul; 29(7):732-739. PubMed ID: 37404072
    [No Abstract]   [Full Text] [Related]  

  • 8. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
    Peter ME; Markley B; DeClercq J; Choi L; Givens G; Zuckerman AD; Banks A
    J Manag Care Spec Pharm; 2021 Feb; 27(2):256-262. PubMed ID: 33506731
    [No Abstract]   [Full Text] [Related]  

  • 9. Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy.
    Peter ME; Zuckerman AD; DeClercq J; Choi L; James C; Cooper K; Choi J; Nadler M; Tanner SB
    J Manag Care Spec Pharm; 2021 Jul; 27(7):882-890. PubMed ID: 34185565
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple modality approach to assess adherence to medications across time in Multiple Sclerosis.
    Neter E; Wolkowitz A; Glass-Marmor L; Lavi I; Ratzabi S; Leibkovitz I; Miller A
    Mult Scler Relat Disord; 2020 May; 40():101951. PubMed ID: 32004857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
    Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient-reported outcomes and pharmacist actions in patients with multiple sclerosis managed by health-system specialty pharmacies.
    Zuckerman AD; Banks AM; Wawrzyniak J; Rightmier E; Simonson D; Zagel AL; Turco E; Blevins A; DeClercq J; Choi L
    Am J Health Syst Pharm; 2023 Nov; 80(22):1650-1661. PubMed ID: 37556317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis.
    Zuckerman AD; DeClercq J; Simonson D; Zagel AL; Turco E; Banks A; Wawrzyniak J; Rightmier E; Blevins A; Choi L
    Mult Scler Relat Disord; 2023 Jul; 75():104738. PubMed ID: 37182475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic.
    Barnes E; Zhao J; Giumenta A; Johnson M
    J Manag Care Spec Pharm; 2020 Feb; 26(2):95-102. PubMed ID: 32011966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.
    Gleason PP; Starner CI; Gunderson BW; Schafer JA; Sarran HS
    J Manag Care Pharm; 2009 Oct; 15(8):648-58. PubMed ID: 19803554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis.
    Ogdie A; Hwang M; Veeranki P; Portelli A; Sison S; Shafrin J; Pedro S; Kim N; Yi E; Michaud K
    J Manag Care Spec Pharm; 2022 Sep; 28(9):1008-1020. PubMed ID: 36001102
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
    Kozma CM; Phillips AL; Meletiche DM
    J Manag Care Spec Pharm; 2014 Aug; 20(8):800-7. PubMed ID: 25062073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.